Medical/Pharmaceuticals
Mentice Launches Seventh Generation Platform Aimed to Transform Endovascular Therapy
VIST® G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications GOTHENBURG, Sweden, May 19, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), today announced the global introduction of its seventh-generation simulation platform - VIST®...
2020-05-19 16:20
2091
Chinese company Daddybaby applies for international PPE certification
FUZHOU, China, May 19, 2020 /PRNewswire/ -- Daddybaby Co. Ltd. has retooled its production lines and joined the fight to deliver more personal protective equipment (PPE) to the populations in many countries. As the daily number of COVID-19 infections inChina has significantly dropped and the situ...
2020-05-19 14:55
1587
Excelra to Provide Lawrence Livermore National Laboratory With Small Molecule Medicinal Chemistry Intelligence Data to Help Develop Drug Design Platform
HYDERABAD, India, May 19, 2020 /PRNewswire/ -- Under a three-year agreement,
Excelra
2020-05-19 10:00
3003
Aetna International announces partnership with leading mental well-being app Wysa, as part of enhanced mental well-being support for members during COVID-19 pandemic
SINGAPORE, May 19, 2020 /PRNewswire/ -- Aetna International has today announced that it is partnering with Wysa, a confidential and anonymous mental well-being app and service, as part of the company's ongoing efforts to address the 'second curve' of the COVID-19 pandemic, the less visible but in...
2020-05-19 10:00
3586
Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam- Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections
SHANGHAI and SAN FRANCISCO, May 19, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial stage biopharmaceutical company, today announced dosing of the first Chinese patient in the global ATTACK (Acinetobacter Treatment Trial Against Colistin) Phase 3 registrational trial...
2020-05-19 09:45
3212
Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic
* Exyte offers the new ExyCell® modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing practice (cGMP). * Univercells Technologies delivers the integrated NevoLine™ biomanufacturing platform, including scale-X™ bioreac...
2020-05-19 08:15
4764
WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States
SHANGHAI and WORCESTER, Mass., May 19, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and the Worcester Business Development Corporation (WBDC) announced today the successful signing of a land deal for WuXi Bio...
2020-05-19 08:00
2933
Medela opens New Production Line in the US and more than Triples Production in Switzerland of Critical Portable Suction Systems Aiding Hospital Ventilator Support and Patients with COVID-19
- Launch of US Vario 18 AC Production Line as Rapid Response to Local Surge of Infection Rates - Expands Access to Vario 18 as well as Dominant Flex and Basic Suction Pumps across the Americas,Europe, Australia, Asia and Saudi Arabia BAAR, Switzerland, May 19, 2020 /PRNewswire/ -- Medela AG, tod...
2020-05-19 07:55
2078
Innovent Biologics and MD Anderson Announce a Strategic Collaboration to Develop anti-PD-1 Therapy TYVYT® (Sintilimab Injection) in Rare Cancers
SUZHOU, China, and HOUSTON, May 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, ...
2020-05-19 07:30
6328
Ortho's COVID-19 IgG Antibody Test Receives CE Mark
- Ortho's IgG test demonstrates 100% specificity and can be used to support decisions for getting people back to work and can support convalescent plasma screening - Ortho's Total antibody test received CE Mark on May 8, 2020 - Ortho's two COVID-19 antibody tests run on Ortho's VITROS® platfo...
2020-05-19 05:33
1712
VeChain and I-Dante Partnered to Create Blockchain Enabled Medical Data Management Platform for Healthcare Provider in Cyprus
SHANGHAI, May 18, 2020 /PRNewswire/ -- With more than 4.6 million infections, 300 thousand deaths and counting caused by COVID-19, national governments, healthcare systems regardless of region and continent have been scrambling to respond to it, and the pandemic has highlighted the increasing dem...
2020-05-18 23:00
4941
Seegene Exports 10 million Corona Tests to Brazil
SEOUL, Korea, May 18, 2020 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced that it will export 10 million tests of its COVID-19 testing kits to Pan American Health Organization (PAHO) / World Health Organization (W...
2020-05-18 21:59
2829
WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
PHILADELPHIA, May 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advanced therapies industry, announced today the expansion of its service capabilities to offer a fully int...
2020-05-18 21:00
2037
ITC Savlon Launches Hand Sanitiser Priced Less Than a Cent
NEW DELHI, May 18, 2020 /PRNewswire/ -- As the world braces to witness the new normal, hand hygiene is emerging as a global priority. The awareness of hand hygiene and the need is now a well-established conversation but often access to hand hygiene becomes a challenge due to lack of facilities an...
2020-05-18 20:27
3505
I Peace, Inc. Begins Clinical-Grade Induced Pluripotent Stem Cells Custom Manufacturing Service
PALO ALTO, Calif., May 15, 2020 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe ), aPalo Alto-based biotech start-up focusing on Nobel Prize-wining technology "induced pluripotent stem cell (iPSC)" began manufacturing clinical-grade iPSCs. We are now officially taking orders for custom manufacturi...
2020-05-16 01:00
2687
China Pharma Holdings, Inc. Reports First Quarter 2020 Financial Results
HAIKOU CITY, China, May 15, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qua...
2020-05-15 18:30
11811
Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting
* STB-C017 is an IDO/TDO dual inhibitor, derived from Syntekabio's proprietary drug discovery artificial intelligence solution, demonstrated powerful immuno-oncologic effect. * Triple combination therapy of STB-C017, PD-1, CTLA-4 immune checkpoint inhibitors (ICIs) presented complete remiss...
2020-05-15 12:01
3724
Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting
DAEJEON, South Korea, May 15, 2020 /PRNewswire/ -- Syntekabio (KOSDAQ: 226330), an AI and NGS based drug development company, presented the result of STB-C017 animal experiments, a small molecule IDO/TDO dual inhibitor derived by Syntekabio's AI drug discovery solution, at the 2020 American Assoc...
2020-05-15 12:01
4325
Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen
* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficac...
2020-05-15 11:52
7513
Innovent Announces Key Results from a Number of Clinical Studies to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
SUZHOU, China, May 15, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseas...
2020-05-15 07:30
7890
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 287 media titles]
2025-01-14 21:00
Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26
Most Read
Hyundai Motor Group Partners with NVIDIA to Accelerate Development of AI Solutions for Future Mobility
2025-01-10 01:00
20545
AIMA Unveils Game-Changing 2025 eBike Lineup at CES: Better Performance, More Freedom
2025-01-09 02:34
6515
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
5849
Boqii Announces ADS Ratio Change
2025-01-11 05:30
5014
Sino Land Included in Dow Jones Sustainability World Index
2025-01-10 22:01
5005
